These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26743473)

  • 1. Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas.
    Mete O; Gomez-Hernandez K; Kucharczyk W; Ridout R; Zadeh G; Gentili F; Ezzat S; Asa SL
    Mod Pathol; 2016 Feb; 29(2):131-42. PubMed ID: 26743473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monomorphous Plurihormonal Pituitary Adenoma of Pit-1 Lineage in a Giant Adolescent with Central Hyperthyroidism.
    Pereira BD; Raimundo L; Mete O; Oliveira A; Portugal J; Asa SL
    Endocr Pathol; 2016 Mar; 27(1):25-33. PubMed ID: 26330191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomas.
    Wang EL; Qian ZR; Yamada S; Rahman MM; Inosita N; Kageji T; Endo H; Kudo E; Sano T
    Endocr Pathol; 2009; 20(4):209-20. PubMed ID: 19774499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plurihormonal pituitary macroadenoma:  a case report.
    Allehaibi E; AlMalki MH; Brema I
    J Med Case Rep; 2021 Jul; 15(1):407. PubMed ID: 34321093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silent subtype 3 pituitary adenoma: a clinicopathologic analysis of the Mayo Clinic experience.
    Erickson D; Scheithauer B; Atkinson J; Horvath E; Kovacs K; Lloyd RV; Young WF
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):92-9. PubMed ID: 19170710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed Gangliocytoma-Pituitary Adenoma: Insights on the Pathogenesis of a Rare Sellar Tumor.
    Lopes MB; Sloan E; Polder J
    Am J Surg Pathol; 2017 May; 41(5):586-595. PubMed ID: 28079576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Pit-1 Immunostaining in Distinguishing Pituitary Adenomas of Primitive Differentiation from Null Cell Adenomas.
    Lee JC; Pekmezci M; Lavezo JL; Vogel H; Katznelson L; Fraenkel M; Harsh G; Dulai M; Perry A; Tihan T
    Endocr Pathol; 2017 Dec; 28(4):287-292. PubMed ID: 28994039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of glycoprotein hormone alpha subunit in somatoprolactinic and pure somatotroph adenomas.
    Vantyghem MC; Cortet C; Bauters C; Gevaert MH; Dewailly D; Lefebvre J; Mazzucca M
    J Endocrinol Invest; 1998; 21(7):434-40. PubMed ID: 9766257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features of silent corticotroph adenomas.
    Alahmadi H; Lee D; Wilson JR; Hayhurst C; Mete O; Gentili F; Asa SL; Zadeh G
    Acta Neurochir (Wien); 2012 Aug; 154(8):1493-8. PubMed ID: 22619024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital analysis of hormonal immunostaining in pituitary adenomas classified according to WHO 2017 criteria and correlation with preoperative laboratory findings.
    Tamanini JVG; Dal Fabbro M; de Freitas LLL; Vassallo J; de Souza Queiroz L; Rogerio F
    Neurosurg Focus; 2020 Jun; 48(6):E12. PubMed ID: 32480373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrastructural and immunoelectron microscopic study of three unusual plurihormonal pituitary adenomas.
    Vidal S; Syro L; Horvath E; Uribe H; Kovacs K
    Ultrastruct Pathol; 1999; 23(3):141-8. PubMed ID: 10445280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Implications of Accurate Subtyping of Pituitary Adenomas: Perspectives from the Treating Physician.
    Gomez-Hernandez K; Ezzat S; Asa SL; Mete Ö
    Turk Patoloji Derg; 2015; 31 Suppl 1():4-17. PubMed ID: 26177314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plurihormonal PIT-1-Positive Pituitary Adenomas: A Systematic Review and Single-Center Series.
    Andrews JP; Joshi RS; Pereira MP; Oh T; Haddad AF; Pereira KM; Osorio RC; Donohue KC; Peeran Z; Sudhir S; Jain S; Beniwal A; Chopra AS; Sandhu NS; Tihan T; Blevins L; Aghi MK
    World Neurosurg; 2021 Jul; 151():e185-e191. PubMed ID: 33862299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical management of clinically silent thyrotropin pituitary adenomas: A single center series of 20 patients.
    Cyprich J; Donoho DA; Brunswick A; Hurth K; Carmichael JD; Weiss MH; Zada G
    J Clin Neurosci; 2020 Jan; 71():70-75. PubMed ID: 31668712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas.
    Nishioka H; Inoshita N; Mete O; Asa SL; Hayashi K; Takeshita A; Fukuhara N; Yamaguchi-Okada M; Takeuchi Y; Yamada S
    Endocr Pathol; 2015 Dec; 26(4):349-55. PubMed ID: 26481628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gonadotroph origin of null cell adenomas.
    Kontogeorgos G; Thodou E
    Hormones (Athens); 2016 Apr; 15(2):243-7. PubMed ID: 27376427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Implications of the New WHO Classification 2017 for Pituitary Tumors.
    Saeger W; Koch A
    Exp Clin Endocrinol Diabetes; 2021 Mar; 129(3):146-156. PubMed ID: 33690870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages.
    Mete O; Alshaikh OM; Cintosun A; Ezzat S; Asa SL
    Endocr Pathol; 2018 Dec; 29(4):332-338. PubMed ID: 30215160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Relevance and Immunohistochemical Patterns of Silent Pituitary Adenomas: 10 Years of Single-centre Experience.
    Akkus G; Karagun B; Çetinalp NE; Açıkalın A; Evran M; Sengöz S; Sert M; Zorludemir S; Tetiker T
    Curr Med Imaging; 2021; 17(2):310-317. PubMed ID: 33357196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.